Search

Financial results - NOVO RESEARCH MED S.R.L.

0.00
Financial Summary - Novo Research Med S.r.l.
Unique identification code: 38835521
Registration number: J16/297/2018
Nace: 7211
Sales - Ron
39.352
Net Profit - Ron
354
Employees
1
Open Account
Company Novo Research Med S.r.l. with Fiscal Code 38835521 recorded a turnover of 2024 of 39.352, with a net profit of 354 and having an average number of employees of 1. The company operates in the field of Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Novo Research Med S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - 5.941 28.901 37.048 27.700 23.585 22.792 39.352
Total Income - EUR - - - 5.941 28.966 37.099 45.919 23.585 22.792 39.352
Total Expenses - EUR - - - 1.204 3.565 9.841 27.155 17.710 22.275 38.636
Gross Profit/Loss - EUR - - - 4.737 25.401 27.257 18.765 5.874 517 716
Net Profit/Loss - EUR - - - 4.559 24.534 26.193 17.553 5.266 289 354
Employees - - - 0 0 0 0 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 73.6%, from 22.792 euro in the year 2023, to 39.352 euro in 2024. The Net Profit increased by 67 euro, from 289 euro in 2023, to 354 in the last year.
Sales - Ron
Net Profit - Ron
Employees
See Company Data

Check the financial reports for the company - Novo Research Med S.r.l.

Rating financiar

Financial Rating -
NOVO RESEARCH MED S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Novo Research Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Novo Research Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Novo Research Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Novo Research Med S.r.l. - CUI 38835521

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - 0 28.196 21.538 49.559 36.469 23.526 10.690
Current Assets - - - 4.975 1.563 34.493 23.029 33.032 12.903 14.251
Inventories - - - 0 0 0 0 0 0 0
Receivables - - - 1.363 1.187 6.516 979 289 586 2.094
Cash - - - 3.612 376 27.978 22.049 32.743 12.317 12.157
Shareholders Funds - - - 4.602 29.047 54.689 71.029 5.314 5.587 5.910
Social Capital - - - 43 42 41 40 41 40 40
Debts - - - 373 711 1.343 1.558 64.187 33.283 21.946
Income in Advance - - - 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7211 - 7211"
CAEN Financial Year 7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 14.251 euro in 2024 which includes Inventories of 0 euro, Receivables of 2.094 euro and cash availability of 12.157 euro.
The company's Equity was valued at 5.910 euro, while total Liabilities amounted to 21.946 euro. Equity increased by 354 euro, from 5.587 euro in 2023, to 5.910 in 2024.
Monitors the Company

Risk Reports Prices

Reviews - Novo Research Med S.r.l.

Comments - Novo Research Med S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.